“showed a trend”

Both parameters were higher in the CVD group, although only the differences for CRP reached statistical significance ( P <0.0001), while the mean NLR showed a trend ( P =0.19) ( Table 1 ).

We found that the RBCK1/HOIL-1L SNV encoding R464H (rs774507518) showed a trend toward an association with primary SS (OR: 2.10, P = 0.19, Table 2 ), though the result was not significant because of limited statistical power.

When soluble protein levels were analyzed as continuous variables using the Cox proportional hazards model, baseline VEGF-C was the only soluble protein significantly associated with TTP by univariate analysis (HR = 0.413; P = 0.0165) and showed a trend towards an association with OS (HR = 0.683; P = 0.190; Table 4 ). sVEGFR-2 ratio to baseline at cycle 1 day 28 was the only soluble protein significantly associated with OS (HR = 0.049; P = 0.0253).

4 ) measured at the first MRI timepoint did not show any difference between the control and GDM groups but showed a trend towards larger mean placental volumes in the GDM group (control: 137.1 cm 3 vs GDM: 152.1 cm 3 , P = 0.19).

While data showed a trend towards higher NRM after MAC [21.4% (95% CI: 12.4-32.1%) vs. 13.1% (95% CI: 6.0-22.9%, P = 0.19], the cumulative incidence of relapse did not show a significant difference [29.3% (95% CI: 18.7–40.7%) vs. 39.2% (95% CI: 26.7-51.4%, P = 0.29] (Table 3 ).

However, after 8 weeks of training, Hb levels showed a trend to increase in proportion in the Und-Und group in comparison with the other training groups: Und-Und: 13.9 ± 1.2 versus 15.0 ± 0.8, Δ% = 8.16, d = 1.10, p = 0.19; Und-Lin: 15.0 ± 0.9 versus 16.2 ± 0.9, Δ% = 7.86, d = 1.26, p = 0.01; Sta-Und: 15.4 ± 0.6 versus 16.5 ± 1.1, Δ% = 7.15, d = 1.33, p = 0.04; Sta-Lin: 15.7 ± 1.0 versus 15.6 ± 0.7, Δ% = − 0.46, d = 0.09, p = 0.81; and control group 14.4 ± 1.3 versus 15.2 ± 0.7, Δ% = 5.20, d = 0.75, p = 0.16.

There were no differences in baseline Glx level between patients who went on to respond to treatment and those who did not, though responders showed a trend to have lower values (14.8 ± 1.2 vs 14.1 ± 0.93 μmol/g, t = 1.38, p = 0.19).

Patients with irAEs showed a trend toward improved OS (median OS 16.4 vs. 6.8 months, p = 0.19) compared to hospitalized patients without documented irAEs.

MK-801 treatment showed a trend toward increasing pAkt-S473 level ( P = .19).

On the other hand, although treatment with tocilizumab showed a trend of improvement in the 28-day mortality as compared to that with the SOC, the improvement was not statistically significant [RR, 0.87 (95% CI, 0.71–1.07), p = 0.19] ( Figure 2B ).

Neutrophils decreased significantly after IL-2 administration ( p = 0.01), while eosinophils showed a trend towards increased numbers in peripheral blood after IL-2 ( p = 0.19).

In ADV-conditioned mice, the frequency and number of CD95 + GL7 + GC B cells increased, and those of class-switched IgG1 + B cells showed a trend to increase (p = 0.19 or 0.18) when compared with those of LD-conditioned mice (Fig. 6F,G ).

Further analysis of the PI3K/PTEN/Akt pathway in the cyclophosphamide-treated samples showed a trend toward a decline in Akt-1 (p = 0.19) and no significant change in the expressions of Foxo3a (p = 0.8) and rpS6 (p = 0.36) (Fig. 3 D–F).

Lower Mcl-1 expression showed a trend towards improved OS ( Figure 3 H; p = 0.19) and correlated significantly with disease-free survival (DFS) ( Figure 3 K; p = 0.03).

Linsitinib significantly reduced T-cell infiltration in the orbital fat of the late TSHR-immunized mice ( Figure 5B ), while the early group showed a trend to reduced T-cell infiltration after treatment with linsitinib (p= 0.19).

Evidence on compliance rate and the risk-reducing effect of aspirin showed a trend to lower incidence of preterm pre-eclampsia with an aspirin adherence ≥90% in comparison to <90% (OR=0.24 vs OR=0.65, p=0.19) 28 .

Subgroup analysis restricted to studies with anthracyclines chemotherapy showed a trend for improvement in heart failure hospitalization with low heterogeneity (RR 0.44, 95% CI 0.13–1.5, P = 0.19; I 2 = 12%).

Patients having a SCF/TGF-α ≤4.4 showed a trend for worse survival compared to those with >4.4 (p=0.190) ( figure 1f ).

Compared to a physical relation, the difference between property and bumping ( M = 4.43, SD = 2.69) showed a trend in the predicted direction that was not statistically significant, t (98) = 1.30, p = .19, d = 0.26.

The mRNA expression of the GPR116 showed a trend towards increased mRNA expression in disturbed flow pattern regions ( P = 0.19).

No subgroup demonstrated a statistically significant association between CTI-WHtR and MACCE in the fully adjusted model, although the elderly subgroup (age ≥ 60 years) approached significance (HR 1.16, 95% CI 1.00–1.34, P = 0.053) and the overweight subgroup (BMI ≥ 24) showed a trend (HR 1.09, 95% CI 0.96–1.25, P = 0.19).

Although the proportion of COX2‐positive cells among PDGFRα‐positive cells showed a trend toward increase after BDL, this did not reach statistical significance ( p = 0.1905) (Figure 6b ).

Ca displayed a higher concentration in the STZ + HT group compared to the vehicle group (vehicle: 384.50 ± 15.00 mg/kg; STZ + HT: 1572.2 ± 386.29 mg/kg; p = 0.0493; Figure 6 A), whereas STZ group showed a trend without a statistic difference (STZ: 793.36 ± 286.68 mg/kg; p = 0.1909).

The si-CCNE1 and cisplatin (60 μg/kg) with an atelocollagen group showed a trend of decreasing tumor weight compared with the si-control and cisplatin (60 μg/kg) group (274.3 ± 136.4 vs. 420.6 ± 216.4, p = 0.191) ( Figure 7 B). 3.

For discharge location, early tracheostomy showed a trend toward more favorable discharge locations (40.0 versus 29.0%, p = 0.192; Table 4 ).